PLD
51
-5
NTAP
58
2
DVN
35
2
HSIC
56
3
CA
36
-4
BLK
69
2
PNR
72
-2
ABT
57
-9
SLG
66
4
INTU
60
-3
AVY
54
-14
BF.B
57
7
EBAY
50
-3
WYNN
34
-3
EXPE
74
2
MS
50
-8
SRE
54
-5
NRG
57
2
PWR
60
-2
COST
51
-3
PLD
51
-5
NTAP
58
2
DVN
35
2
HSIC
56
3
CA
36
-4
BLK
69
2
PNR
72
-2
ABT
57
-9
SLG
66
4
INTU
60
-3
AVY
54
-14
BF.B
57
7
EBAY
50
-3
WYNN
34
-3
EXPE
74
2
MS
50
-8
SRE
54
-5
NRG
57
2
PWR
60
-2
COST
51
-3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
21

VYGR
Voyager Therapeutics

Last Price:
6.47
Seasonality Move:
-14.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager

Voyager Therapeutics Price Quote

$6.47
+0.23 (+3.69%)
(Updated: September 19, 2024 at 12:20 PM ET)

Voyager Therapeutics Key Stats

Sell
21
Voyager Therapeutics (VYGR) is a Sell
Day range:
$6.18 - $6.48
52-week range:
$5.97 - $11.72
Dividend yield:
0%
P/E ratio:
2.10
P/S ratio:
2.27
P/B ratio:
1.01%
Volume:
418.9K
Avg. volume:
405.8K
1-year change:
-23.48%
Market cap:
$340.3M
Revenue:
$250M
EPS:
$0.22

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 5.09%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.6M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.2M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$263.5M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 3.5%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 2.42%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 3.5%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.7%
Revenue: 509.48% 210.88%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.63
Upside from Last Price: 182.45%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.4M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    2.9M VYGR shares are owned by insiders